Bass, Berry & Sims member Dale Grimes is quoted in the Law360 article, “Express Scripts’ $29B Medco Buy May Face Antitrust Test,” discussing the potential antitrust issues raised by the proposed deal between rival pharmacy benefit managers Express Scripts and Medco. Mr. Grimes employs his extensive knowledge of antitrust investigations to explain moves by Express Scripts that suggest that the deal is unlikely to be approved by regulators.